Showing 1 - 10 of 2,294
Persistent link: https://www.econbiz.de/10011986910
This report reviews the important role of medicines in health systems, describes recent trends in pharmaceutical expenditure and financing, and summarises the approaches used by OECD countries to determine coverage and pricing. It then highlights current issues for policy makers, such as the...
Persistent link: https://www.econbiz.de/10012450998
Persistent link: https://www.econbiz.de/10000508255
pharmaceutical products. Illicit markets for fake pharmaceuticals are attractive for counterfeiters, given the high profit margins … dangerous ingredients. Fake pharmaceuticals include antibiotics, lifestyle treatments, pain killers, anti-malarial drugs …
Persistent link: https://www.econbiz.de/10012451513
Persistent link: https://www.econbiz.de/10011971571
Antimicrobial resistance (AMR) is a large and growing problem with the potential for enormous health and economic consequences, globally. As such, AMR has become a central issue at the top of the public health agenda of OECD countries and beyond. In this report, OECD used advanced techniques,...
Persistent link: https://www.econbiz.de/10012451043
Persistent link: https://www.econbiz.de/10015054455
This report draws a range of new analyses and case studies carried out in preparation for the Accra High-Level Forum held in September 2008. It it is organized into four parts. Part 1 examines trends in aid for health from a global perspective, focusing both on how increases in aid finance have...
Persistent link: https://www.econbiz.de/10012441711
neglected infectious disease, according to the World Health Organisation. Yet less than 1% of the new drugs placed on the market …
Persistent link: https://www.econbiz.de/10012448189
Persistent link: https://www.econbiz.de/10003410196